vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Burke & Herbert Financial Services Corp. (BHRB). Click either name above to swap in a different company.
Burke & Herbert Financial Services Corp. is the larger business by last-quarter revenue ($86.5M vs $44.9M, roughly 1.9× AbCellera Biologics Inc.). Burke & Herbert Financial Services Corp. runs the higher net margin — 34.9% vs -19.9%, a 54.9% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 4.9%). Burke & Herbert Financial Services Corp. produced more free cash flow last quarter ($96.2M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 81.1%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Burke & Herbert Financial Services Corp is a U.S.-based regional financial holding company, offering personal and commercial banking, wealth management, residential mortgage lending, and small business financing services. Its core market covers Virginia and adjacent Mid-Atlantic regions, serving retail consumers, SMEs, and high-net-worth clients.
ABCL vs BHRB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $86.5M |
| Net Profit | $-8.9M | $30.2M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | 43.8% |
| Net Margin | -19.9% | 34.9% |
| Revenue YoY | 788.4% | 4.9% |
| Net Profit YoY | 73.9% | 52.8% |
| EPS (diluted) | $-0.03 | $1.98 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $86.5M | ||
| Q3 25 | $9.0M | $85.4M | ||
| Q2 25 | $17.1M | $87.1M | ||
| Q1 25 | $4.2M | $83.0M | ||
| Q4 24 | $5.0M | $82.5M | ||
| Q3 24 | $6.5M | $83.8M | ||
| Q2 24 | $7.3M | $69.3M | ||
| Q1 24 | $10.0M | $26.4M |
| Q4 25 | $-8.9M | $30.2M | ||
| Q3 25 | $-57.1M | $30.0M | ||
| Q2 25 | $-34.7M | $29.9M | ||
| Q1 25 | $-45.6M | $27.2M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | $-51.1M | $27.6M | ||
| Q2 24 | $-36.9M | $-16.9M | ||
| Q1 24 | $-40.6M | $5.2M |
| Q4 25 | -63.7% | 43.8% | ||
| Q3 25 | -851.8% | 43.3% | ||
| Q2 25 | -290.2% | 42.7% | ||
| Q1 25 | -1479.6% | 39.6% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | -1439.4% | 39.2% | ||
| Q2 24 | -1276.2% | -27.5% | ||
| Q1 24 | -551.5% | 22.3% |
| Q4 25 | -19.9% | 34.9% | ||
| Q3 25 | -637.8% | 35.1% | ||
| Q2 25 | -203.3% | 34.3% | ||
| Q1 25 | -1077.2% | 32.8% | ||
| Q4 24 | — | 24.0% | ||
| Q3 24 | -785.4% | 33.0% | ||
| Q2 24 | -504.3% | -24.4% | ||
| Q1 24 | -408.0% | 19.8% |
| Q4 25 | $-0.03 | $1.98 | ||
| Q3 25 | $-0.19 | $1.97 | ||
| Q2 25 | $-0.12 | $1.97 | ||
| Q1 25 | $-0.15 | $1.80 | ||
| Q4 24 | — | $1.72 | ||
| Q3 24 | $-0.17 | $1.82 | ||
| Q2 24 | $-0.13 | $-1.41 | ||
| Q1 24 | $-0.14 | $0.69 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $854.6M |
| Total Assets | $1.4B | $7.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | $966.9M | $854.6M | ||
| Q3 25 | $964.0M | $822.2M | ||
| Q2 25 | $1.0B | $780.0M | ||
| Q1 25 | $1.0B | $758.0M | ||
| Q4 24 | $1.1B | $730.2M | ||
| Q3 24 | $1.1B | $738.1M | ||
| Q2 24 | $1.1B | $693.1M | ||
| Q1 24 | $1.1B | $319.3M |
| Q4 25 | $1.4B | $7.9B | ||
| Q3 25 | $1.4B | $7.9B | ||
| Q2 25 | $1.4B | $8.1B | ||
| Q1 25 | $1.3B | $7.8B | ||
| Q4 24 | $1.4B | $7.8B | ||
| Q3 24 | $1.4B | $7.9B | ||
| Q2 24 | $1.4B | $7.8B | ||
| Q1 24 | $1.5B | $3.7B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $107.9M |
| Free Cash FlowOCF − Capex | $-44.6M | $96.2M |
| FCF MarginFCF / Revenue | -99.4% | 111.2% |
| Capex IntensityCapex / Revenue | 21.9% | 13.5% |
| Cash ConversionOCF / Net Profit | — | 3.57× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $164.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $107.9M | ||
| Q3 25 | $-52.6M | $39.3M | ||
| Q2 25 | $-32.4M | $41.0K | ||
| Q1 25 | $-11.6M | $37.6M | ||
| Q4 24 | $-108.6M | $85.8M | ||
| Q3 24 | $-28.9M | $47.8M | ||
| Q2 24 | $-30.0M | $-46.0M | ||
| Q1 24 | $-41.7M | $7.1M |
| Q4 25 | $-44.6M | $96.2M | ||
| Q3 25 | $-61.5M | $35.4M | ||
| Q2 25 | $-45.8M | $-3.4M | ||
| Q1 25 | $-22.2M | $35.9M | ||
| Q4 24 | $-187.0M | $81.2M | ||
| Q3 24 | $-47.4M | $46.0M | ||
| Q2 24 | $-50.1M | $-47.0M | ||
| Q1 24 | $-65.8M | $5.6M |
| Q4 25 | -99.4% | 111.2% | ||
| Q3 25 | -687.0% | 41.5% | ||
| Q2 25 | -267.9% | -3.9% | ||
| Q1 25 | -524.0% | 43.2% | ||
| Q4 24 | -3702.8% | 98.5% | ||
| Q3 24 | -728.4% | 55.0% | ||
| Q2 24 | -683.8% | -67.8% | ||
| Q1 24 | -661.5% | 21.2% |
| Q4 25 | 21.9% | 13.5% | ||
| Q3 25 | 99.7% | 4.5% | ||
| Q2 25 | 78.2% | 3.9% | ||
| Q1 25 | 251.1% | 2.1% | ||
| Q4 24 | 1552.7% | 5.5% | ||
| Q3 24 | 284.6% | 2.1% | ||
| Q2 24 | 274.6% | 1.5% | ||
| Q1 24 | 242.5% | 5.7% |
| Q4 25 | — | 3.57× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 1.38× | ||
| Q4 24 | — | 4.33× | ||
| Q3 24 | — | 1.73× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
